Literature DB >> 22584585

PSMA7 inhibits the tumorigenicity of A549 human lung adenocarcinoma cells.

Jia-Yu Tan1, Xiang Huang, Ya-Ling Luo.   

Abstract

The gene for proteasome subunit alpha type-7 (PSMA7) is located in chromosomal 20q13.33, a region frequently amplified in tumor. In this study, we employed A549 human lung adenocarcinoma cells and showed that PSMA7 inhibits the proliferation, tumorigenicity and invasion of A549 cells in vitro. Moreover, both gain and loss of function studies demonstrated that PSMA7 modulates the tumorigenicity of A549 cells in a xenograft nude mice model. In conclusion, these results identify inhibitory effects associated with PSMA7 that affect the tumorigenicity of A549 cells, suggesting PSMA7 as a potential tumor biomarker.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584585     DOI: 10.1007/s11010-012-1290-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  11 in total

1.  The proteasome subunit PSMA7 located on the 20q13 amplicon is overexpressed and associated with liver metastasis in colorectal cancer.

Authors:  Xiao-tong Hu; Wei Chen; Da Wang; Qing-Lan Shi; Fu-Biao Zhang; Yong-Qiang Liao; Mei Jin; Chao He
Journal:  Oncol Rep       Date:  2008-02       Impact factor: 3.906

2.  Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.

Authors:  M Krüger; C Beger; P J Welch; J R Barber; M P Manns; F Wong-Staal
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex.

Authors:  Z Zhang; N Torii; A Furusaka; N Malayaman; Z Hu; T J Liang
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

4.  Proteasome complex as a potential cellular target of hepatitis B virus X protein.

Authors:  J Huang; J Kwong; E C Sun; T J Liang
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity.

Authors:  S Ohnami; N Matsumoto; M Nakano; K Aoki; K Nagasaki; T Sugimura; M Terada; T Yoshida
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

6.  Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits.

Authors:  G Sébastien Apcher; Sylvia Heink; Daniela Zantopf; Peter-M Kloetzel; Hans-P Schmid; R John Mayer; Elke Krüger
Journal:  FEBS Lett       Date:  2003-10-09       Impact factor: 4.124

Review 7.  O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1.

Authors:  Gregg L Semenza
Journal:  J Appl Physiol (1985)       Date:  2004-03

8.  Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.

Authors:  Luigi Scotto; Gopeshwar Narayan; Subhadra V Nandula; Hugo Arias-Pulido; Shivakumar Subramaniyam; Achim Schneider; Andreas M Kaufmann; Jason D Wright; Bhavana Pothuri; Mahesh Mansukhani; Vundavalli V Murty
Journal:  Genes Chromosomes Cancer       Date:  2008-09       Impact factor: 5.006

9.  Endothelial monocyte activating polypeptide-II modulates endothelial cell responses by degrading hypoxia-inducible factor-1alpha through interaction with PSMA7, a component of the proteasome.

Authors:  Anita T Tandle; Maura Calvani; Badarch Uranchimeg; David Zahavi; Giovanni Melillo; Steven K Libutti
Journal:  Exp Cell Res       Date:  2009-04-10       Impact factor: 3.905

10.  Identification and analysis of tumour-associated antigens in hepatocellular carcinoma.

Authors:  Y-Y Shi; H-C Wang; Y-H Yin; W-S Sun; Y Li; C-Q Zhang; Y Wang; S Wang; W-F Chen
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

View more
  7 in total

1.  [Expression of PSMA 7 and its effect on proliferation, invasion, migration and tumorigenesis of gastric cancer].

Authors:  Shujing Xia; Lili Zhang; Fenggan Cheng; Zhenqing Feng; Lungen Lu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-04-30

2.  In Silico Identification of Hub Genes as Observing Biomarkers for Gastric Cancer Metastasis.

Authors:  Arulprakasam Ajucarmelprecilla; Jhansi Pandi; Ranjithkumar Dhandapani; Saikishore Ramanathan; Jayaprakash Chinnappan; Ragul Paramasivam; Sathiamoorthi Thangavelu; Abdul-Kareem Mohammed Ghilan; Saad Ali S Aljohani; Atif Abdulwahab A Oyouni; Abdullah Farasani; Malik A Altayar; Hussam Awwadh E Althagafi; Othman R Alzahrani; Kaliannan Durairaj; Anupama Shrestha
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-30       Impact factor: 2.650

3.  Identification of potential biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma by bioinformatics analysis.

Authors:  Bo Yang; Zhifeng Chen; Yu Huang; Guoxu Han; Weizhong Li
Journal:  Onco Targets Ther       Date:  2017-04-26       Impact factor: 4.147

4.  Integrated Analysis of Transcriptome and Prognosis Data Identifies FGF22 as a Prognostic Marker of Lung Adenocarcinoma.

Authors:  Hong-Yan Liu; Hui Zhao; Wen-Xing Li
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

5.  Overexpression of PSMA7 predicts poor prognosis in patients with gastric cancer.

Authors:  Shujing Xia; Qi Tang; Xudong Wang; Lili Zhang; Lizhou Jia; Duo Wu; Pingxiang Xu; Xiumei Zhang; Genxiong Tang; Tingting Yang; Zhenqing Feng; Lungen Lu
Journal:  Oncol Lett       Date:  2019-09-19       Impact factor: 2.967

6.  Bioinformatics analysis of molecular genetic targets and key pathways for hepatocellular carcinoma.

Authors:  Junxue Tu; Jingjing Chen; Meimei He; Hongfei Tong; Haibin Liu; Bin Zhou; Yi Liao; Zhaohong Wang
Journal:  Onco Targets Ther       Date:  2019-07-02       Impact factor: 4.147

7.  DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension.

Authors:  Yi Yan; Yang-Yang He; Xin Jiang; Yong Wang; Ji-Wang Chen; Jun-Han Zhao; Jue Ye; Tian-Yu Lian; Xu Zhang; Ru-Jiao Zhang; Dan Lu; Shan-Shan Guo; Xi-Qi Xu; Kai Sun; Su-Qi Li; Lian-Feng Zhang; Xue Zhang; Shu-Yang Zhang; Zhi-Cheng Jing
Journal:  Sci Adv       Date:  2020-12-09       Impact factor: 14.136

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.